staging and mets

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/73

encourage image

There's no tags or description

Looks like no tags are added yet.

74 Terms

1
New cards

penile stage 2

invades corpus spongiosum with or without urethral invasion

2
New cards

penile stage 3

invades corpora cavernosa with or without urethral invasion

3
New cards

penile stage 4

invades other adjacent structures such as scrotum, prostate, pubic bone

4
New cards

most common non-nodal sites of metastasis for penile cancer

liver, heart, lungs

5
New cards

prostate pT1

does not exist

6
New cards

prostate pT2

organ confined

7
New cards

prostate pT3

EPE, microscopic invasion of bladder neck, invasion of seminal vesicles

8
New cards

prostate pT4

tumor fixed or invades adjacent structures other than seminal vesicles such as external sphincter, rectum, bladder, levator muscles, pelvic wall

9
New cards

most common non-nodal sites of mets for prostate cancer

pelvic and lumbar spine

10
New cards

most common molecular alteration in prostate cancer

TMPRSS2-ERG

11
New cards

testes pT1

tumor limited to the testis without LVI

12
New cards

testes pT2

tumor limited to testes with LVI or tumor invading hilar ST or epididymis or penetrating visceral mesothelial layer covered the external surface of tunica albuginea with or without LVI

13
New cards

testes pT3

tumor directly invades spermatic cord ST with or without LVI

14
New cards

testes pT4

invades scrotum with or without LVI

15
New cards

most common site of mets for testicular cancer

lymph nodes, lung, liver, brain, bone

16
New cards

lung pT1

tumor less than or equal to 3 surrounded by lung or visceral pleura

17
New cards

lung pT2

tumor greater than 3 cm but less than or equal to 5 cm; involves any of the following: main bronchus, visceral pleura, associated with atelectasis or obstructive pneumonitis,

18
New cards

lung pT3

greater than 5 cm but less than or equal to 7 cm; involving any of the following: parietal pleura, chest wall, phrenic nerve, parietal pericardium, or separate nodule in the same lobe’

19
New cards

lung pT4

tumor greater than 7 or involves any of the following: diaphragm, mediastinum, heart, great vessels, trachea, recurrent laryngeal n, esophagus, vertebral body, carina; separate nodule in different lobe

20
New cards

lung PL1

tumor invasion beyond the elastic layer of the visceral pleura

21
New cards

lung PL2

tumor invasion to the visceral pleural surface

22
New cards

lung metastatic areas

adrenal, liver, bone, brain, other lung

23
New cards

adenocarcinoma presentation

solid, firm, grey/yellow, peripherally located, well-defined, women, non-smokers

24
New cards

squamous cell carcinoma presentation

white/grey, cauliflower-like, centrally located, central necrotic, males and smokers

25
New cards

most common molecular alterations for NSCLC

KRAS, EGFR, ALK

26
New cards

carcinoid tumor presentation

well-circumscribed, tan-white/pink, homogenous, most commonly within mainstream bronchi, MEN1

27
New cards

most common IHCs for carcinoid tumor

synaptophysin, chromogranin A

28
New cards

lung bx

88305

29
New cards

lung wedge

88307

30
New cards

total/lobe/segment resection

88309

31
New cards

paraglottic space

deep to ventricles

32
New cards

pre-epiglottic space

in front of the glottis

33
New cards

invasion of pre-epiglottic and/or paraglottic spaces means

pT3

34
New cards

pT4 for laryngeal tumors

through thyroid cartilage

35
New cards

what happens if laryngectomy frozen margins are positive

alters patient management and may mean post surgery radiation therapy

36
New cards

most important prognostic factor for laryngeal cancers

regional lymph node status

37
New cards

laryngeal cancer mets to

lung

38
New cards

larynx bx

88305

39
New cards

larynx, partial/total without nodes

88307

40
New cards

larynx, partial/total, with nodes

88309

41
New cards

most important prognostic factor for pharyngeal cancer

cervical lymph node status

42
New cards

oral cavity pT1

tumor less than or equal to 2cm, DOI less than or equal to 5mm

43
New cards

oral cavity pT2

tumor less than or equal to 2cm with DOI greater than 5mm

tumor greater than 2cm but less than 4 cm with DOI less than 10 mm

44
New cards

oral cavity pT3

tumor greater than 2cm but less than 4cm with DOI greater than 10 mm

tumor greater than 4cm with DOI less than 10 mm

45
New cards

oral cavity pT4

tumor greater than 4cm with DOI greater than 10 mm

or tumor invades cortical bone

46
New cards

strongest predictor of recurrence and survival for oral cavity cancer

margin status

47
New cards

tongue, excision for tumor

88309

48
New cards

mandible/maxilla, tumor resection

88309

49
New cards

lip, bx or wedge resection

88305

50
New cards

maxillary sinus pT1

limited to maxillary sinus mucosa with no erosion or destruction of bone

51
New cards

maxillary sinus pT2

tumor causes bone erosion or destruction including extension into the hard palate or middle nasal meatus

52
New cards

maxillary sinus pT3

tumor invades the following: bone of posterior maxillary sinus, subcutaneous tissues, floor or medial wall of orbit, pterygoid fossa, ethmoid sinuses

53
New cards

maxillary sinus pT4

local disease; tumor invades anterior orbital contents, skin of cheek, pterygoid plates, infratemportal fossa, cribriform plate, sphenoid, front sinuses, orbital apex, dura, brain, middle cranial fossa, cranial nerves other than maxillary, nasopharynx, clivus

54
New cards

radical neck dissection

includes levels I-V to include submandibular gland, SCM, IJV, spinal accessory nerve

55
New cards

modified radical neck dissection

levels I-V but spaces one or more of spinal accessory nerve, SCM, and IJV

56
New cards

selective neck dissection

less than 5 traditional levels

57
New cards

superselective neck dissection

fibrofatty elements of 2 levels or less

58
New cards

RLN for H&N criteria

one or multiple, ENE + or -, ipsilateral or contralateral nodes, size of metastatic deposit

59
New cards

lymph node excision

88307

60
New cards

lymph node regional resection

88307

61
New cards

most common thyroid cancer

PTC

62
New cards

most aggressive thyroid cancer

anapestic thyroid cancer

63
New cards

thyroid cancer arises from C cells

medullary thyroid cancer

64
New cards

thyroid pT1

limited to thyroid, less than or equal to 2 cm

65
New cards

thyroid pT2

limited to thyroid, greater than 2 but less than or equal to 4 cm

66
New cards

thyroid pT3

limited to thyroid and greater than 4 cm; or gross extrathyroidal extension invading only strap muscles

67
New cards

thyroid pT4

includes extra thyroidal extension beyond strap muscles

68
New cards

medullary thyroid cancer is associated with

MEN2 and RET mutations

69
New cards

thyroid resection

88307

70
New cards

salivary gland pT1

2 cm or smaller

71
New cards

salivary gland pT2

greater than 2 but less than or equal to 4 cm

72
New cards

salivary gland pT3

greater than 4 cm or has extraparenchymal extension

73
New cards

salivary gland pT4

advanced disease invading skin, mandible, ear canal, facial nerve, skull base or pterygoid plates, or encases carotid artery

74
New cards